Abstract | OBJECTIVE: METHODS: Experimental TBI was induced in Sprague-Dawley rats by a controlled cortical impact device, functioning at a velocity of 3 m/s to produce a 2-mm deformation. Ifenprodil or saline (10 mg/kg) was injected intraperitoneally immediately after the cortical impact injury and then every 90 minutes until 6 hours after TBI. Blood-brain barrier breakdown was evaluated quantitatively 6 hours after injury by fluorometric assay of Evans blue extravasation. Brain water content, an indicator of brain edema, was measured with the wet-dry method 24 hours after TBI. Injury volume was quantitated from the brain slices stained with 2% cresyl violet solution 7 days after TBI. RESULTS: Blood-brain barrier breakdown was significantly lower in the traumatic cortex of the ifenprodil-treated group than in the saline-treated group (84.4 +/- 26.8 microg/g versus 161.8 +/- 27 microg/g, respectively, P < 0.05). Brain edema was significantly reduced in the cortex of the ifenprodil-treated group relative to that in the saline-treated group (80.9 +/- 0.5% versus 82.4 +/- 0.6% respectively, P < 0.05). Ifenprodil treatment reduced injury volume significantly (14.9 +/- 8.1 mm3 versus 24.4 +/- 6.7 mm3, P < 0.05). CONCLUSION: The polyamine-site NMDA receptor antagonist ifenprodil affords significant neuroprotection in a controlled cortical impact brain injury model and may hold promise for the discovery and treatment of the mechanism of delayed neurological deficits after TBI.
|
Authors | R J Dempsey, M K Başkaya, A Doğan |
Journal | Neurosurgery
(Neurosurgery)
Vol. 47
Issue 2
Pg. 399-404; discussion 404-6
(Aug 2000)
ISSN: 0148-396X [Print] United States |
PMID | 10942013
(Publication Type: Journal Article)
|
Chemical References |
- Excitatory Amino Acid Antagonists
- Piperidines
- Polyamines
- Receptors, N-Methyl-D-Aspartate
- ifenprodil
|
Topics |
- Animals
- Blood-Brain Barrier
(drug effects)
- Body Water
(metabolism)
- Brain
(metabolism)
- Brain Edema
(drug therapy)
- Brain Injuries
(drug therapy, pathology, physiopathology)
- Capillary Permeability
(drug effects)
- Excitatory Amino Acid Antagonists
(therapeutic use)
- Male
- Piperidines
(therapeutic use)
- Polyamines
(metabolism)
- Rats
- Rats, Sprague-Dawley
- Receptors, N-Methyl-D-Aspartate
(antagonists & inhibitors, metabolism)
|